Showing results (161-170 of 219) with videos related to
Sort By:
Pageof 22
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 9, 2016
Age- and Tumor Subtype-Specific Breast Cancer Risk Estimates for CHEK2*1100delC CarriersMarjanka K Schmidt, Frans Hogervorst, Richard van Hien, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 29, 2012
Common breast cancer susceptibility variants in LSP1 and RAD51L1 are associated with mammographic density measures that predict breast cancer riskCeline M Vachon, Christopher G Scott, Peter A Fasching, et al.Plos Genetics|April 2, 2013
Evidence of gene-environment interactions between common breast cancer susceptibility loci and established environmental risk factorsStefan Nickels, Thérèse Truong, Rebecca Hein, et al.International Journal of Cancer|September 18, 2014
Investigation of gene-environment interactions between 47 newly identified breast cancer susceptibility loci and environmental risk factorsAnja Rudolph, Roger L Milne, Thérèse Truong, et al.Breast Cancer Research : BCR|April 8, 2015
Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with prognosis of estrogen receptor-negative breast cancer after chemotherapyJieping Lei, Anja Rudolph, Kirsten B Moysich, et al.Nature Communications|June 18, 2014
2q36.3 is associated with prognosis for oestrogen receptor-negative breast cancer patients treated with chemotherapyJingmei Li, Linda S Lindström, Jia N Foo, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 11, 2015
Fine-scale mapping of the 4q24 locus identifies two independent loci associated with breast cancer riskXingyi Guo, Jirong Long, Chenjie Zeng, et al.Human Molecular Genetics|July 13, 2016
An intergenic risk locus containing an enhancer deletion in 2q35 modulates breast cancer risk by deregulating IGFBP5 expressionAsaf Wyszynski, Chi-Chen Hong, Kristin Lam, et al.Plos Medicine|August 24, 2016
Genetically Predicted Body Mass Index and Breast Cancer Risk: Mendelian Randomization Analyses of Data from 145,000 Women of European DescentYan Guo, Shaneda Warren Andersen, Xiao-Ou Shu, et al.Plos One|August 25, 2016
Fine-Mapping of the 1p11.2 Breast Cancer Susceptibility LocusHisani N Horne, Charles C Chung, Han Zhang, et al.Pageof 22